Location History:
- Oak Park, CA (US) (2013)
- Thousand Oaks, CA (US) (2014)
Company Filing History:
Years Active: 2013-2014
Title: Belle Bei Liu: Innovator in Pharmaceutical Development
Introduction
Belle Bei Liu is a prominent inventor based in Thousand Oaks, CA (US). She has made significant contributions to the field of pharmaceuticals, particularly in the development of anti-angiogenic drugs. Her innovative work has led to the filing of multiple patents, showcasing her expertise and dedication to advancing medical science.
Latest Patents
Belle Bei Liu holds 2 patents, with her latest inventions focusing on the anti-angiogenic drug AMG 706. One of her patents details a process for making a solid-state form of AMG 706, which is provided in amorphous form. This patent also includes the development of an AMG 706-crystallization inhibitor composite, which comprises particles of amorphous AMG 706 in association with one or more crystallization inhibitors, such as polymers. Additionally, she has developed methods and compositions for making and using polymorphs of cinacalcet hydrochloride, further demonstrating her innovative capabilities in pharmaceutical formulations.
Career Highlights
Belle Bei Liu has established herself as a key figure in the pharmaceutical industry through her work at Amgen Inc. Her research and development efforts have contributed to the advancement of treatments for various medical conditions, particularly those requiring anti-angiogenic therapies. Her commitment to innovation is evident in her successful patent applications and the impact of her work on patient care.
Collaborations
Throughout her career, Belle has collaborated with notable colleagues, including Nina Cauchon and Pengzu Zhou. These partnerships have fostered a collaborative environment that enhances the development of groundbreaking pharmaceutical solutions.
Conclusion
Belle Bei Liu is a remarkable inventor whose contributions to the pharmaceutical industry have made a significant impact. Her innovative patents and collaborative efforts continue to advance medical science and improve treatment options for patients.